LU84613A1 - Nouvelles compositions pharmaceutiques administrables par voie nasale - Google Patents
Nouvelles compositions pharmaceutiques administrables par voie nasale Download PDFInfo
- Publication number
- LU84613A1 LU84613A1 LU84613A LU84613A LU84613A1 LU 84613 A1 LU84613 A1 LU 84613A1 LU 84613 A LU84613 A LU 84613A LU 84613 A LU84613 A LU 84613A LU 84613 A1 LU84613 A1 LU 84613A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- pharmaceutical composition
- composition according
- substance
- ciliary function
- stimulating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8202781 | 1982-02-01 | ||
| GB8202781 | 1982-02-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU84613A1 true LU84613A1 (fr) | 1983-09-08 |
Family
ID=10528017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU84613A LU84613A1 (fr) | 1982-02-01 | 1983-01-31 | Nouvelles compositions pharmaceutiques administrables par voie nasale |
Country Status (27)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0715285D0 (en) * | 2007-08-06 | 2007-09-12 | Britannia Pharmaceuticals Ltd | Improvements in or relating to powdered medicaments for nasal delivery |
| GB0910375D0 (en) * | 2009-06-16 | 2009-07-29 | Biocopea Ltd | Drug composition and its use in therapy |
| JP7317020B2 (ja) * | 2018-01-05 | 2023-07-28 | インペル ファーマシューティカルズ インコーポレイテッド | 精密嗅覚デバイスによるジヒドロエルゴタミンの鼻腔内送達 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3091569A (en) * | 1960-08-26 | 1963-05-28 | Mead Johnson & Co | Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus |
| GB1202885A (en) * | 1966-12-22 | 1970-08-19 | Sandoz Ltd | Pharmaceutical compositions comprising alkaloids |
| DE2750090A1 (de) * | 1976-11-19 | 1978-06-01 | Sandoz Ag | Neue verabreichungsformen fuer organische verbindungen |
| FR2387035A1 (fr) * | 1977-04-12 | 1978-11-10 | Cassenne Lab Sa | Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux |
| DE2831728C2 (de) * | 1978-07-19 | 1982-12-23 | Krewel-Werke Gmbh, 5208 Eitorf | Arzneimittel zur Behandlung von Kopfschmerzen |
-
1983
- 1983-01-25 FI FI830245A patent/FI81258C/fi not_active IP Right Cessation
- 1983-01-27 FR FR8301228A patent/FR2539994B1/fr not_active Expired
- 1983-01-28 PH PH28445A patent/PH22198A/en unknown
- 1983-01-28 CH CH495/83A patent/CH653555A5/de not_active IP Right Cessation
- 1983-01-28 AU AU10850/83A patent/AU565613B2/en not_active Expired
- 1983-01-28 NZ NZ203117A patent/NZ203117A/en unknown
- 1983-01-28 NL NL8300325A patent/NL192325C/nl not_active IP Right Cessation
- 1983-01-29 DE DE19833302949 patent/DE3302949A1/de active Granted
- 1983-01-31 AT AT0030383A patent/AT385656B/de not_active IP Right Cessation
- 1983-01-31 SE SE8300495A patent/SE454402B/sv not_active IP Right Cessation
- 1983-01-31 GR GR70362A patent/GR81320B/el unknown
- 1983-01-31 IE IE187/83A patent/IE54532B1/en not_active IP Right Cessation
- 1983-01-31 PT PT76166A patent/PT76166B/pt unknown
- 1983-01-31 BE BE1/10708A patent/BE895750A/fr not_active IP Right Cessation
- 1983-01-31 HU HU83323A patent/HU191512B/hu unknown
- 1983-01-31 CA CA000420539A patent/CA1197783A/en not_active Expired
- 1983-01-31 JP JP58015392A patent/JPS58134017A/ja active Granted
- 1983-01-31 DK DK038183A patent/DK164771C/da not_active IP Right Cessation
- 1983-01-31 LU LU84613A patent/LU84613A1/fr unknown
- 1983-02-01 ES ES519450A patent/ES8502865A1/es not_active Expired
- 1983-02-01 IL IL67822A patent/IL67822A/xx not_active IP Right Cessation
- 1983-02-01 IT IT47646/83A patent/IT1197558B/it active
- 1983-02-01 ZA ZA83673A patent/ZA83673B/xx unknown
-
1987
- 1987-12-30 MY MY766/87A patent/MY8700766A/xx unknown
-
1989
- 1989-05-25 SG SG343/89A patent/SG34389G/en unknown
- 1989-06-21 KE KE3888A patent/KE3888A/xx unknown
- 1989-07-27 HK HK599/89A patent/HK59989A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2602974A1 (fr) | Composition pharmaceutique contenant de la nicotine ou ses derives | |
| BE1005778A5 (fr) | Utilisation amelioree de medicaments bronchodilatateurs beta2-stimulants. | |
| FR2588189A1 (fr) | Composition pharmaceutique de type a transition de phase liquide-gel | |
| BE1006233A3 (fr) | Composition pour application nasale. | |
| US5169849A (en) | Nasal pharmaceutical compositions | |
| EP0479005A1 (fr) | Composition pharmaceutique sous forme de gel dans un emballage distributeur | |
| FR2514642A1 (fr) | Compositions pharmaceutiques a liberation retardee | |
| FR2533826A1 (fr) | Nouvelles compositions galeniques a base de calcitonine | |
| EP0131477B1 (fr) | Utilisation d'un sel de l'acide N-acetyl (alpha, beta) aspartylglutamique pour la préparation d'un médicament à activité anti-allergique pour administration locale | |
| CA2370581A1 (fr) | Nouvelles compositions pharmaceutiques comprenant des derives de 8-isoxazole-2-aminotetralines | |
| CH680191A5 (US20100268047A1-20101021-C00004.png) | ||
| LU84613A1 (fr) | Nouvelles compositions pharmaceutiques administrables par voie nasale | |
| FR2618333A1 (fr) | Composition pharmaceutique et/ou cosmetique a usage topique contenant de la gomme rhamsam | |
| EP3027064B1 (fr) | Composition pharmaceutique, diététique ou alimentaire liquide ou semi-liquide dépourvue d'amertume contenant un sel d'arginine | |
| FR2884716A1 (fr) | Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires | |
| FR2757398A1 (fr) | Formulation de bambuterol et son utilisation | |
| GB2114001A (en) | Nasal pharmaceutical compositions | |
| CH674937A5 (US20100268047A1-20101021-C00004.png) | ||
| FR2518882A1 (fr) | Composition therapeutique, a base de monophosphate d'inosine, pour le traitement des troubles d'accommodation de l'oeil | |
| BE897904A (fr) | Nouvelles compositions galeniques a base de calcitonine | |
| EP2258354B1 (fr) | Composés et méthodes pour contrôler la prise d'alcool. | |
| EP0323762B1 (fr) | Nouvelles compositions anti-tussives et leur procédé d'obtention | |
| EP0433140B1 (fr) | Nouvelle préparation pharmaceutique anti-allergique à action prolongée | |
| FR2773076A1 (fr) | Utilisation de la flavine-adenine-dinucleotide pour la preparation de compositions ophtalmiques utiles pour le traitement de l'oeil sec | |
| WO1999052520A1 (fr) | Composition aqueuse ionique contenant du levomenthol |
